reports
- Laura Chico
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
ITCI INTRA-CELLULAR THERAPIES INC.
CTRN CITI TRENDS INC.
RDI READING INTERNATIONAL INC.
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
NHF NEXPOINT CREDIT STRATEGIES FUN
NINE NINE ENERGY SERVICE INC
LILA LIBERTY LATIN AMERICA A
MCFT MASTERCRAFT BOAT HOLDINGS
HQL TEKLA LIFE SCIENCES INVESTORS
ATHA ATHIRA PHARMA
NUVB NUVATION BIO INC (A)
PX P10 INC
PROK PROKIDNEY CORP.
GNT GABELLI NATURAL RESOURCES
PEO GOLD AND INCOME TRUST
DMA PETROLEUM & RESOURCES CORPORATION
NRBO DESTRA MULTI ALTERNATIVE FUND
NEUROBO PHARMACEUTICALS INC
- Valens Research
QRVO - Valens Credit Report - 2024 06 04
Credit markets are slightly overstating ROST's credit risk with a YTW of 5.762% relative to an Intrinsic YTW of 5.192% and an Intrinsic CDS of 61bps. Incentives Dictate Behavior™ analysis highlights mixed signals for credit holders. As positives, most management members are material owners of ROST equity relative to their annual compensation, indicating they may be well-aligned with shareholders to pursue long-term value creation for the company. Also, most members of management have low change...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Rotation is the Lifeblood of a Bull Market Semiconductors (SMH, SOXX, NVDA, AVGO, etc.) have been leadership since late-2022, but they are extended and are starting to see some profit taking as market participants rotate into other areas of the market that have been lagging (especially Energy, and to a lesser extent banks and small-caps). The question is whether this new trend lasts a few days, or if this is the start of longer-term trend. We would not be surprised to see more consolidation for...
WM WASTE MANAGEMENT INC.
TTEK TETRA TECH INC.
TJX TJX COMPANIES INC
ROST ROSS STORES INC.
ROL ROLLINS INC.
NBIX NEUROCRINE BIOSCIENCES INC.
ITCI INTRA-CELLULAR THERAPIES INC.
HALO HALOZYME THERAPEUTICS INC.
CLH CLEAN HARBORS INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
IONS IONIS PHARMACEUTICALS INC.
RSG REPUBLIC SERVICES INC.
UTHR UNITED THERAPEUTICS CORPORATION
WCN WASTE CONNECTIONS INC.
MDGL MADRIGAL PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
PCVX VAXCYTE
Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Ac...
Data from Phase 2 ACcomplisH Trial of TransCon CNP in Children with Achondroplasia Presented at ICCHBH 2024 • Data demonstrate significant improvements in well-being and physical functioning compared to placebo in patients treated for 1 year with TransCon CNP at the pivotal 100μg/kg/week dose • Improvements could not be explained by changes in linear growth only, supporting a potential additional direct treatment effect of TransCon CNP beyond linear growth COPENHAGEN, Denmark, June 24, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced the oral presentation of ...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
SRPT SAREPTA THERAPEUTICS INC.
SPR SPIRIT AEROSYSTEMS HOLDINGS INC. CLASS A
MNKD MANNKIND CORP.
BCRX BIOCRYST PHARMACEUTICALS INC.
ALNY ALNYLAM PHARMACEUTICALS INC
AGIO AGIOS PHARMACEUTICALS INC.
RY4C RYANAIR HOLDINGS PLC
LILA LIBERTY LATIN AMERICA A
DNLI DENALI THERAPEUTICS INC
ADT ADT INC
HROW HARROW HEALTH INC.
TWST TWIST BIOSCIENCE
DYN DYNE THERAPEUTICS
SMLP SUMMIT MIDSTREAM PARTNERS
RNA AVIDITY BIOSCIENCES
TNGX TANGO THERAPEUTICS INC
RYAN RYAN SPECIALTY GROUP HLDGS INC
RKLB ROCKET LAB USA INC
BTMD HAYMAKER ACQUISITION CORP III
IBRX IMMUNITYBIO INC
CDRO CODERE ONLINE LUXEMBOURG SA
XPOF XPONENTIAL FITNESS INC
UBXG U BX TECHNOLOGY LTD
FTLF FITLIFE BRANDS INC.
- Dave Nicoski
- Ross LaDuke
Vermilion Int'l Compass: Global Equity Strategy
Downgrading Europe to Market Weight Not much has changed since our latest Int'l Compass from May 31, 2024 titled "Buy the Pullback." As the title suggested, we were buyers of the pullback in global equities (MSCI ACWI, ACWI ex-US, EAFE, EM, Europe, Japan, Taiwan, etc.) due to important short-term supports holding, combined with ongoing healthy market dynamics. Supports are holding, and our bullish outlook (since early-November 2023) remains intact. Continue to buy dips. Downgrading Europe to M...
- Wedbush Research
XENE XENON PHARMACEUTICALS INC
V VISA INC. CLASS A
SAGE SAGE THERAPEUTICS INC.
NBIX NEUROCRINE BIOSCIENCES INC.
IMAX IMAX CORPORATION
FL FOOT LOCKER INC.
DKS DICK'S SPORTING GOODS INC.
CNK CINEMARK HOLDINGS INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
CMG CHIPOTLE MEXICAN GRILL INC.
DRI DARDEN RESTAURANTS INC.
NKE NIKE INC. CLASS B
STOK STOKE THERAPEUTICS
SNOW SNOWFLAKE INC. CLASS A
LBPH LONGBOARD PHARMACEUTICALS
TOST TOAST INC
SOUN SOUNDHOUND AI INC
EWTX EDGEWISE THERAPEUTICS INC
- Laura Chico
Moody's Ratings announces completion of a periodic review of ratings o...
Moody's Ratings (Moody's) has completed a periodic review of the ratings of TJX Companies, Inc. (The) and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 June 2024 in which Moody's reassessed the appropriateness of the ratings in th...
Intra-Cellular Therapies Announces Positive Topline Results in Second ...
Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder In Study 502, lumateperone 42 mg achieved statistically significant and clinically meaningful results in both the primary and the key secondary endpoints Lumateperone 42 mg met the primary endpoint of change from baseline at Week 6 on the Montgomery-Åsberg Depression Rating Scale (MADRS) total score versus placebo (4.5 point reduction v. placebo; p
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ROL ROLLINS INC.
PSIX POWER SOLUTIONS INTERNATIONAL INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
LMAT LEMAITRE VASCULAR INC.
IRT INDEPENDENCE REALTY TRUST INC.
HAS HASBRO INC.
ESS ESSEX PROPERTY TRUST INC.
CDNS CADENCE DESIGN SYSTEMS INC.
ADBE ADOBE INC.
NFLX NETFLIX INC.
TTC TORO COMPANY
USM UNITED STATES CELLULAR CORP
USLM U.S. LIME & MINERALS
URGN UROGEN PHARMA
AVGO BROADCOM INC.
SPOT SPOTIFY TECHNOLOGY SA
FRHC FREEDOM HOLDING CORP
DCTH DELCATH SYSTEMS
TERN TERNS PHARMACEUTICALS
SMMT SUMMIT THERAPEUTICS INC
MEG MONTROSE ENVIRONMENTAL GROUP
ALHC ALIGNMENT HEALTHCARE INC
MITT AG MORTGAGE INVESTMENT TRUST INC
APP APPLOVIN CORP
ASTS AST SPACEMOBILE INC
NU NU HLDGS LTD
BRCC BRC INC
NGNE NEUROGENE INC
AKA AKA BRANDS HOLDING CORP
INST INSTRUCTURE HLDGS INC
SYRS SYROS PHARMACEUTICALS INC.
AUID AUTHID INC
NLCP NEWLAKE CAPITAL PARTNERS INC COM
- Laura Chico
Halozyme Therapeutics Inc: 1 director
A director at Halozyme Therapeutics Inc sold 20,000 shares at 50.315USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Mixed Signals, Reasons for Caution The S&P 500 uptrend remains intact, and the same can be said for the QQQ's. Despite a positive view of these two metrics, the aspect of of failed U.S. dollar breakdown coupled with the reversal. of the 10-year yields higher does give us pause. The S&P 500 breadth is showing signs of breadth divergence. 1.) The U.S. dollar has staged a false breakdown and is now on the cusp of a reversal. A decisive close through last Friday's close of 104.89 could yet negate t...
TJX TJX COMPANIES INC
SXT SENSIENT TECHNOLOGIES CORPORATION
MATX MATSON INC.
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC.
ASC ARDMORE SHIPPING
SBL SAFE BULKERS INC.
GNK GENCO SHIPPING & TRADING LTD.
LCM COSTAMARE INC.
ROST ROSINTER RESTAURANTS HOLDING ORD SHS
SBLK STAR BULK CARRIERS CORP.
KEX KIRBY CORPORATION
NMM NAVIOS MARITIME PARTNERS
DAC DANAOS
HSHP HIMALAYA SHIPPING LTD.
ESEA EUROSEAS LTD
Waste Management Inc: 1 director
A director at Waste Management Inc sold 4,208 shares at 204.285USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
- Research Team ACF
Regenerative Healthcare - Stem Cells & ALS Thematic 10062024
Regenerative medicine remains an extremely exciting area of healthcare with vast investment potential. In spite of the usual setbacks in valuation and strategy, the sub-sector has pivoted and the market remains innovative and attracts investment capital. Rather than replace entire tissues, which is a complex activity, we believe the immediate future for stem cells is more likely to be in the successful stimulation of the bodies on repair mechanisms. Within regenerative medicine we believe there ...
NOVN NOVARTIS AG
CG3 CELGENE CORPORATION
QURE UNIQURE NV
MRK MERCK & CO. INC.
JNJ JOHNSON & JOHNSON
GILD GILEAD SCIENCES INC.
CYTK CYTOKINETICS INCORPORATED
BMY BRISTOL-MYERS SQUIBB COMPANY
BIIB BIOGEN INC.
BCLI BRAINSTORM CELL THERAPEUTICS
SAN SANOFI
4523 EISAI CO. LTD.
IONS IONIS PHARMACEUTICALS INC.
WVE WAVE LIFE SCIENCES
PFE PFIZER INC.
ABBV ABBVIE INC.
AMRX AMNEAL PHARMACEUTICALS INC. CLASS A
TEVA TEVA PHARMACEUTICAL INDUSTRIES LIMITED
NOVO NOVO NORDISK A/S-B
Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs G...
Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 45th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2024 at 10:00 a.m. ET in Miami, FL. The live and archived webcast can be accesse...
Rollins Inc: 1 director
A director at Rollins Inc sold 12,000 shares at 47.200USD and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.